Unlocking the health benefits of cannabinoids.

We are a team of medical experts.

Medical Advisory Board

Our Medical Advisory Board is made up of renowned Healthcare Professionals whose unique perspectives and expertise inform the strategic direction and success of the company.

Political Advisory Board

Our Political Advisory Board comprises renowned political experts and healthcare professionals who provide strategic guidance and advice to support Sanity Group to meet its mission and objectives.

Latest News

Coalition Agreement Presented: Sanity Group Welcomes Planned Evaluation of Cannabis Law and Calls for Scientific Pilot Projects

The coalition agreement presented today by CDU/CSU and SPD includes an important announcement for the German cannabis industry: The new government plans an unbiased evaluation of the Cannabis Act in autumn 2025, which came into force in April 2024. The aim is to review the current state of the regulated handling of cannabis and, if necessary, make adjustments. Berlin-based cannabis company Sanity Group welcomes this step – and simultaneously calls for the timely approval of scientific pilot projects for the regulated distribution of recreational cannabis.

Read more

Cannabis Dispensaries in the German Capital: Sanity Group Plans Scientific Pilot Projects with Two Berlin Districts

During a press conference, the district governments of Friedrichshain-Kreuzberg and Neukölln announced today their plans to implement scientifically monitored pilot projects for the sale of recreational cannabis through licensed dispensaries. Following Frankfurt am Main and Hanover, these two Berlin districts are now the third major urban areas in Germany planning a comprehensive study aimed at harm reduction through the legal sale of recreational cannabis. The Berlin-based cannabis company Sanity Group, which has been operating dispensaries for a similar scientific pilot project in Switzerland’s Basel-Landschaft canton for about a year, will also be responsible for the operational management of the dispensaries in Berlin, as it will be in Frankfurt and Hanover.

Read more

Sanity Group Secures Additional Growth Capital Amounting to a Total of 17 Million Euros

Sanity Group GmbH, one of Germany’s leading cannabis companies, announced the completion of an investment from the Jupiter Fund of Organigram Holdings Inc., a leading licensed cannabis producer based in Toronto, Canada, today. This marks Organigram’s first investment in the European cannabis market. Using funds from the Jupiter Fund, the Canadian producer is investing 14 million euros in the form of a convertible loan into Sanity Group. Additionally, the company has the option to call for a second tranche of three million euros as part of the convertible loan. Simultaneously with the investment, Organigram and Sanity Group have agreed on a new supply agreement to deepen their partnership, which has been in place since 2023.

Read more